|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.66 USD | +2.89% |
|
+7.53% | +14.87% |
Evolution of the Average Target: LB Pharmaceuticals Inc
Evolution of the Target Price: LB Pharmaceuticals Inc
Changes in Analyst Recommendations: LB Pharmaceuticals Inc
c1586a9f6668fae4b4755066872d318.HherUd74o0BYOAJTuEDq-L4nHyAd13goZJ2mkqOj5mA.J1TqO5TJ7iIKaVsHiDm7tc8RfkJsrTtnJu3P65H6gipTU5kIq7aXDRFqbQ~8910284ad9bcef2e617d042a71aba99f
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +78.43% | |||||
| +36.54% | |||||
| +44.84% | |||||
| +52.33% | |||||
| +45.34% | |||||
| +29.24% | |||||
| +28.11% | |||||
| +57.06% | |||||
| +103.03% | |||||
| +38.38% | |||||
| Average | +51.33% | |||||
| Weighted average by Cap. | +45.39% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
24.94USD
Average target price
44.50USD
Spread / Average Target
+78.43%
High Price Target
78.00USD
Spread / Highest target
+212.75%
Low Price Target
31.00USD
Spread / Lowest Target
+24.30%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| Roth Capital Partners | |
| Leerink Partners | |
| Piper Sandler | |
| Stifel Nicolaus |
SellBuy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
24.94USD
Average target price
44.50USD
Spread / Average Target
+78.43%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LBRX Stock
- Consensus LB Pharmaceuticals Inc
Select your edition
All financial news and data tailored to specific country editions
